RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
RXDX
Delisted
RXDX was delisted on the 15th of June, 2023.
116 hedge funds and large institutions have $870M invested in Prometheus Biosciences, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 35 increasing their positions, 36 reducing their positions, and 16 closing their positions.
Holders
116
Holders Change
+13
Holders Change %
+12.62%
% of All Funds
1.96%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.08%
New
31
Increased
35
Reduced
36
Closed
16
Calls
$1.36M
Puts
$13.9M
Net Calls
-$12.6M
Net Calls Change
-$18M
Top Buyers
Top Sellers
1 |
PA
1
Perceptive Advisors
New York
|
$47.5M |
2 |
2
State Street
Boston,
Massachusetts
|
$13.7M |
3 |
3
Norges Bank
Oslo,
Norway
|
$13.8M |
4 |
4
BlackRock
New York
|
$51.2M |
5 |
DTC
5
Deep Track Capital
Greenwich,
Connecticut
|
$0 |